Trade Summary

4 days ago, HERSHBERG ROBERT, serving as Dir at Adaptive Biotechnologies Corp (ADPT), sold 30,664 shares at $24.40 per share, for a total transaction value of $748,208.24. Following this transaction, HERSHBERG ROBERT now holds 46,683 shares of ADPT.

This sale represents a 39.64% decrease in HERSHBERG ROBERT's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, August 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 5:55 PM ET, 2 days after the trade was made.

Adaptive Biotechnologies Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.